EXACT SCIENCES CORP — Regulatory Filings 2014

Mar 21, 2014

*UNITED STATES*

*SECURITIES AND EXCHANGE COMMISSION*

*Washington, D.C. 20549*

*FORM 8-K*

*CURRENT REPORT*

*Pursuant to Section 13 or 15(d) of the*

*Securities Exchange Act of 1934*

Date of Report (Date of earliest event reported): March 17, 2014

*EXACT SCIENCES CORPORATION*

(Exact Name of Registrant as Specified in Charter)

Delaware	000-32179	02-0478229
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

*441 Charmany Drive*

*Madison, WI 53719*

(Address of Principal Executive Offices)(Zip Code)

Registrant’s telephone number, including area code: (608) 284-5700

*Not Applicable*

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

SEQ.=1,FOLIO='',FILE='C:\JMS\C901770\14-8709-1\task6643859\8709-1-ba.htm',USER='C901770',CD='Mar 21 18:49 2014'

*Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers*

On March 17, 2014, James Connelly submitted his resignation as a member of the Board of Directors of Exact Sciences Corporation (the “Company”). Mr. Connelly did not indicate that his resignation was a result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

*Item 8.01 Other Events*

On March 21, 2014, the Company issued a press release reporting the appointment of Kevin Conroy as chairman of the board and the appointment of David Thompson as lead independent director. The press release is filed herewith as Exhibit 99.

*Item 9.01. Financial Statements and Exhibits.*

*Exhibits*

The exhibits required to be filed as a part of this Current Report on Form 8-K are listed in the Exhibit Index attached hereto and incorporated herein by reference.

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\C901770\14-8709-1\task6643859\8709-1-ba.htm',USER='C901770',CD='Mar 21 18:49 2014'

*SIGNATURES*

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

/s/ Maneesh Arora
Maneesh Arora
Chief Operating Officer

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\C901770\14-8709-1\task6643859\8709-1-ba.htm',USER='C901770',CD='Mar 21 18:49 2014'

*EXHIBIT INDEX*

Exhibit No.	Exhibit Description
99	Press release, dated March 21, 2014.

4

SEQ.=1,FOLIO='4',FILE='C:\JMS\C901770\14-8709-1\task6643859\8709-1-ba.htm',USER='C901770',CD='Mar 21 18:49 2014'